Recurrent UTI - Stop the Cycle

Recurrent urinary tract infection is defined as 3 or more culture-proven UTIs in 12 months, or 2 or more in 6 months. A culture-proven UTI means a urine sample sent to the lab that grows a significant number of bacteria - not just a positive dipstick, and not symptoms alone. Many patients self-diagnose and self-treat UTIs based on symptoms, which means the recurrence rate may appear lower or different to what actually occurred. Before embarking on a prevention strategy, it is essential to confirm that previous episodes were genuine UTIs with positive cultures - some patients have bladder pain syndrome or OAB that mimics UTI symptoms without true infection.

Recurrent UTI has several distinct causes that need to be identified: Anatomical: incomplete bladder emptying (post-void residual urine provides a culture medium), kidney or bladder stones, urethral diverticulum, vesicoureteral reflux, or fistula (rare). Behavioural/lifestyle: infrequent voiding, inadequate fluid intake, sexual intercourse pattern. Hormonal: post-menopausal women have reduced vaginal oestrogen, causing loss of Lactobacillus-dominated microbiome and increased uropathogen colonisation - the most common cause of recurrent UTI in older women. Immunological: diabetes mellitus impairs immune response to bacteria. In men: any recurrent UTI warrants prostate assessment (chronic prostatitis as a reservoir), bladder outflow assessment, and upper tract imaging.

Cranberry products (juice or capsules) contain A-type proanthocyanidins (PACs) that prevent E. coli from adhering to the bladder wall. Evidence from randomised trials is mixed - cranberry is more likely to help in pre-menopausal women with recurrent E. coli UTIs, less so in post-menopausal women or in men. Cranberry juice has very high sugar content and is not recommended as the primary strategy. Concentrated cranberry tablets (36mg PAC per tablet, twice daily) are more practical. Cranberry reduces but rarely eliminates recurrent UTI on its own - it is best used alongside other prevention strategies rather than as a standalone treatment.

Continuous low-dose antibiotic prophylaxis involves taking a low dose of an antibiotic (trimethoprim 100mg, nitrofurantoin 50mg, or cefalexin 125mg) every night or every other night to prevent UTI recurrence. It reduces recurrent UTI frequency by approximately 95% while taking it. Duration is typically 6–12 months. Side effects are generally minor at low doses. Post-prophylaxis recurrence rates are similar to pre-treatment, so it is a suppressive rather than curative strategy. Before starting prophylaxis, a complete anatomical workup must be done - prophylaxis while a structural cause is present may be masking a fixable problem.

In pre-menopausal women where UTIs are clearly triggered by sexual intercourse, a single dose of antibiotic taken within 2 hours of intercourse (trimethoprim 200mg, nitrofurantoin 100mg, or cefalexin 500mg) effectively prevents post-coital UTI. This is far preferable to continuous prophylaxis as antibiotic exposure is much lower and only occurs when needed. Voiding after intercourse also reduces risk. Post-coital prophylaxis is highly effective for the subset of women with clearly intercourse-associated recurrent UTI.

Standard workup for recurrent UTI includes: urine microscopy and culture (confirm true infection, identify organism and sensitivity pattern), ultrasound of kidneys and bladder (assess post-void residual, stones, structural abnormality), flexible cystoscopy (in adults over 40, or with haematuria, or atypical organisms - to exclude bladder tumour, diverticulum, or foreign body), blood glucose and HbA1c (exclude diabetes), vaginal examination and swabs (women - assess atrophic vaginitis, vaginal discharge), and in men: PSA, flow rate, post-void residual, assessment for chronic prostatitis. CT urogram is arranged if upper tract stones or abnormality is suspected.